compared with placebo , 3 months of bepridil therapy resulted in a significant reduction in the weekly frequency of angina from 10.3 +/- 9.1 to 1.8 +/- 3.5 ( p less than 0.002 ) and nitroglycerin consumption from 5.0 +/- 5.4 to 1.4 +/- 2.3 ( p less than 0.01 ) .
C0005116
bepridil
C0002962
angina